Welcome to the 2nd Annual Gene Therapy Analytical Development

With unprecedented levels of investment and an increasing number of programs progressing through the clinic, the establishment of robust gene therapy analytical strategies is more important than ever.

This focused, niche agenda will delve into the analytical challenges encountered in every stage of the gene therapy development life cycle, offering more content than ever before:


Exploring the latest analytical developments in developing and validating bioassays:

  • The methodology behind in vivo and in vitro potency assays
  • Analyzing potency assays
  • Strategies for overcoming common challenges


Analyzing technology advances for titre assays for gene therapy products:

  • Contrasting quantitative PCR (qPCR) and digital PCR (dPCR)
  • Determining genome and capsid titre
  • Genome sequencing approaches


Discussing the limitations and advantages of biochemical assays to analyze an attribute:

  • High-performance liquid chromatography (HPLC)
  • Capillary gel electrophoresis (CGE)
  • Mass spectrometry (MS)
  • Analytical ultracentrifugation (AUC)

Register Interest For The Gene Therapy Analytical Development Summit 2021